Literature DB >> 27464746

Response to comment on "NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis".

Hui Wang1, Monserrat Rojo de la Vega2, Donna D Zhang3, Shicang Yu4, Hongting Zheng5.   

Abstract

Multiple factors may affect the outcome of diabetic patients with cancer treated with antioxidant antidiabetic agents.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27464746     DOI： 10.1126/scitranslmed.aag1805

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  2 in total

1.  SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170.

Authors:  Sarallah Rezazadeh; David Yang; Gregory Tombline; Matthew Simon; Sean P Regan; Andrei Seluanov; Vera Gorbunova
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

Review 2.  Antioxidant Activity during Tumor Progression: A Necessity for the Survival of Cancer Cells?

Authors:  Mark A Hawk; Chelsea McCallister; Zachary T Schafer
Journal:  Cancers (Basel)       Date:  2016-10-13       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.